Topics
May/June 2026 | Letter to the Editors - Online Exclusive
Beyond One-Size-Fits-All: The Move Toward Personalized Vitreoretinal Therapy
By calculating the vitreous volume exact, clinicians can treat eyes with greater precision.
Andreas F. Borkenstein, MD
August 17, 2026
Duravyu Misses Primary Endpoint in Phase 3 LUGANO Trial but Reduces Treatment Burden in Wet AMD
August 14, 2026
Large UK Study Examines Impact of Anti-VEGF Treatment for DME on Progression to Proliferative Diabetic Retinopathy
August 13, 2026
First Patient Receives Investigational Regenerative Cell Therapy for Non-Syndromic Retinitis Pigmentosa
Prevent Blindness Raises Concerns Over Proposed Head Start Vision Screening Changes
July/August 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
July/August 2026 Supplement
Editorially Independent Content, Supported With Advertising From Astellas
Editorially Independent Content, Supported With Advertising From Astellas and ZEISS
July 2026 Supplement
Free Print Subscription
Email Newsletter
Conference Calendar
_1784132761.jpg?auto=compress,format&w=70)
